Weiss Amir's most recent trade in Teva- Pharmaceutical Industries Ltd. - ADR was a trade of 3,537 Restricted Share Units done . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 3,537 | 10,613 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2026 | 3,537 | 30,695 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 11,280 | 11,280 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 10,679 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 10,679 | 21,508 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 5,650 | 27,158 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 5,650 | 11,300 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 5,179 | 10,829 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 5,179 | 5,180 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 30.20 per share. | 16 Dec 2025 | 12,300 | 5,650 (0%) | 0% | 30.2 | 371,504 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 24.44 per share. | 06 Nov 2025 | 12,300 | 17,950 (0%) | 0% | 24.4 | 300,564 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 14,150 | 14,150 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 3,566 | 30,250 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 3,566 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 10,676 | 10,679 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 10,676 | 21,034 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 5,650 | 16,950 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 5,650 | 26,684 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,179 | 10,359 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,179 | 10,358 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 15 May 2024 | 15,500 | 17,814 (0%) | 0% | 16.8 | 260,417 | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 15 May 2024 | 12,635 | 5,179 (0%) | 0% | 16.7 | 210,377 | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 05 Mar 2024 | 3,564 | 3,566 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 05 Mar 2024 | 3,564 | 33,314 (0%) | 0% | - | Ordinary Shares | ||
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 22,600 | 22,600 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 10,676 | 21,355 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 10,676 | 29,750 (0%) | 0% | - | Ordinary Shares | ||
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 5,179 | 19,074 (0%) | 0% | - | Ordinary Shares | ||
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 03 Mar 2024 | 5,179 | 15,538 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Weiss Amir | Chief Accounting Officer | 28 Feb 2024 | 3,219 | 13,895 (0%) | 0% | - | Ordinary Shares | ||
| Teva- pharma Ind Ltd (ADR) | Amir Weiss | Chief Accounting Officer | 28 Feb 2024 | 3,219 | 0 | - | - | Restricted Share Units | ||
| Teva- pharma Ind Ltd (ADR) | Weiss Amir | Chief Accounting Officer | 01 Feb 2024 | 31,766 | 10,676 (0%) | 0% | 12.4 | 392,955 | Ordinary Shares |